The role of miR-130a-3p and SPOCK1 in tobacco exposed bronchial epithelial BEAS-2B transformed cells: Comparison to A549 and H1299 lung cancer cell lines

References

• Bartel, D. P. 2009. MicroRNAs: Target recognition and regulatory functions. Cell 136:215–33. doi:10.1016/j.cell.2009.01.002.
   PubMed Web of Science ®Google Scholar
• Bartels, C. L., and G. J. Tsongalis. 2009. MicroRNAs: Novel biomarkers for human cancer. Clin. Chem. 55:623–31. doi:10.1373/clinchem.2008.112805.
   PubMed Web of Science ®Google Scholar
• Boll, K., K. Reiche, K. Kasack, N. Morbt, A. K. Kretzschmar, J. M. Tomm, G. Verhaegh, J. Schalken, M. von Bergen, F. Horn, et al. 2013. MiR-130a, miR-203 and miR-205 jointly repress key oncogenic pathways and are downregulated in prostate carcinoma. Oncogene 32:277–85. doi:10.1038/onc.2012.55.
   PubMed Web of Science ®Google Scholar
• Centers for Disease, Control and Prevention (CDC). 2010. Racial disparities in smoking-attributable mortality and years of potential life lost — Missouri, 2003-2007. Morb. Mortal. Wkly. Rep 59: 1518–22.
   PubMedGoogle Scholar
• Chen, D. H., H. H. Zhou, G. Y. Liu, Y. H. Zhao, G. Cao, and Q. H. Liu. 2018. SPOCK1 promotes the invasion and metastasis of gastric cancer through Slug-induced epithelial-mesenchymal transition. J. Cell. Mol. Med. 22:797–807. doi:10.1111/jcmm.13357.
   PubMed Web of Science ®Google Scholar
• Chen, J. S., D. D. Yan, W. L. Wu, J. Zhu, W. S. Ye, and Q. Shu. 2016. MicroRNA-130a promotes the metastasis and epithelial-mesenchymal transition of osteosarcoma by targeting PTEN. Oncol. Rep. 35:3285–92. doi:10.3892/or.2016.4719.
   PubMed Web of Science ®Google Scholar
• Cory, G. 2011. Scratch-wound assay. Meth. Mol. Biol. 769:25–30. doi:10.1007/978-1-61779-207-6_2.
   PubMedGoogle Scholar
• Damps, I., E. Jassem, and A. Sieminska. 2001. Molecular basis of carcinogenesis in lung cancer induced by cigarette smoking. Pol. Merkur. Lekarski 10:403–04.
   PubMedGoogle Scholar
• Denisenko, T. V., I. N. Budkevich, and B. Zhivotovsky. 2018. Cell death-based treatment of lung adenocarcinoma. Cell Death Dis. 9:117. doi:10.1038/s41419-017-0063-y.
   PubMed Web of Science ®Google Scholar
• Drago-Garcia, D., J. Espinal-Enriquez, and E. Hernandez-Lemus. 2017. Network analysis of EMT and MET micro-RNA regulation in breast cancer. Sci. Rep. 7:13534. doi:10.1038/s41598-017-13903-1.
   PubMedGoogle Scholar
• Du, H., J. Sun, Z. Chen, J. Nie, J. Tong, and J. Li. 2012. Cigarette smoke-induced failure of apoptosis resulting in enhanced neoplastic transformation in human bronchial epithelial cells. J. Toxicol. Environ. Health Part A 75:707–20. doi:10.1080/15287394.2012.690088.
   PubMed Web of Science ®Google Scholar
• Dykxhoorn, D. M. 2010. MicroRNAs and metastasis: Little RNAs go a long way. Cancer Res. 70:6401–06. doi:10.1158/0008-5472.CAN-10-1346.
   PubMed Web of Science ®Google Scholar
• Fujita, Y., T. Kojima, K. Kawakami, K. Mizutani, T. Kato, T. Deguchi, and M. Ito. 2015. miR-130a activates apoptotic signaling through activation of caspase-8 in taxane-resistant prostate cancer cells. Prostate 75:1568–78. doi:10.1002/pros.23031.
   PubMed Web of Science ®Google Scholar
• Giannakakis, A., G. Coukos, A. Hatzigeorgiou, R. Sandaltzopoulos, and L. Zhang. 2007. miRNA genetic alterations in human cancers. Expert. Opin. Biol. Ther. 7:1375–86. doi:10.1517/14712598.7.9.1375.
   PubMed Web of Science ®Google Scholar
• He, L., H. Y. Wang, L. Zhang, L. Huang, J. D. Li, Y. Xiong, M. Y. Zhang, W. H. Jia, J. P. Yun, R. Z. Luo, et al. 2014. Prognostic significance of low DICER expression regulated by miR-130a in cervical cancer. Cell Death Dis. 5:e1205. doi:10.1038/cddis.2014.127.
   PubMed Web of Science ®Google Scholar
• Hu, B., H. Zhang, Z. Wang, F. Zhang, H. Wei, and L. Li. 2017. LncRNA CCAT1/miR-130a-3p axis increases cisplatin resistance in non-small-cell lung cancer cell line by targeting SOX4. Cancer Biol. Ther. 18:974–83. doi:10.1080/15384047.2017.1385679.
   PubMed Web of Science ®Google Scholar
• Jaca, A., P. Govender, M. Locketz, and R. Naidoo. 2017. The role of miRNA-21 and epithelial mesenchymal transition (EMT) process in colorectal cancer. J. Clin. Pathol. 70:331–56. doi:10.1136/jclinpath-2016-204031.
   PubMed Web of Science ®Google Scholar
• Jiang, H., W. W. Yu, L. L. Wang, and Y. Peng. 2015. miR-130a acts as a potential diagnostic biomarker and promotes gastric cancer migration, invasion and proliferation by targeting RUNX3. Oncol. Rep. 34:1153–61. doi:10.3892/or.2015.4099.
   PubMed Web of Science ®Google Scholar
• Kabakov, A. E., and V. L. Gabai. 2018. Cell death and survival assays. Meth. Mol. Biol. 1709:107–27. doi:10.1007/978-1-4939-7477-1_9.
   PubMedGoogle Scholar
• Kawauchi, T. 2012. Cell adhesion and its endocytic regulation in cell migration during neural development and cancer metastasis. Int. J. Mol. Sci. 13:4564–90. doi:10.3390/ijms13044564.
   PubMed Web of Science ®Google Scholar
• Lambert, A. W., D. R. Pattabiraman, and R. A. Weinberg. 2017. Emerging biological principles of metastasis. Cell 168:670–91. doi:10.1016/j.cell.2016.11.037.
   PubMed Web of Science ®Google Scholar
• Lei, C., F. Du, L. Sun, T. Li, T. Li, Y. Min, A. Nie, X. Wang, L. Geng, Y. Lu, et al. 2017. miR-143 and miR-145 inhibit gastric cancer cell migration and metastasis by suppressing MYO6. Cell Death Dis. 8:e3101. doi:10.1038/cddis.2017.493.
   PubMed Web of Science ®Google Scholar
• Lin, L., H. B. Lin, L. Wang, B. Wang, X. Z. Hao, and Y. K. Shi. 2015. miR-130a regulates macrophage polarization and is associated with non-small cell lung cancer. Oncol. Rep. 34:3088–96. doi:10.3892/or.2015.4301.
   PubMed Web of Science ®Google Scholar
• Ma, L. J., W. J. Wu, Y. H. Wang, T. F. Wu, P. I. Liang, I. W. Chang, H. L. He, and C. F. Li. 2016. SPOCK1 overexpression confers a poor prognosis in urothelial carcinoma. J. Cancer 7:467–76. doi:10.7150/jca.13625.
   PubMed Web of Science ®Google Scholar
• Omar Zaki, S. S., L. Kanesan, M. Y. D. Leong, and S. Vidyadaran. 2019. The influence of serum-supplemented culture media in a transwell migration assay. Cell Biol. Int. doi:10.1002/cbin.11122.
   PubMed Web of Science ®Google Scholar
• Pan, Y., R. Wang, F. Zhang, Y. Chen, Q. Lv, G. Long, and K. Yang. 2015. MicroRNA-130a inhibits cell proliferation, invasion and migration in human breast cancer by targeting the RAB5A. Int. J. Clin. Exp. Pathol. 8:384–93.
   PubMedGoogle Scholar
• Ratert, N., H. A. Meyer, M. Jung, P. Lioudmer, H. J. Mollenkopf, I. Wagner, K. Miller, E. Kilic, A. Erbersdobler, S. Weikert, et al. 2013. miRNA profiling identifies candidate miRNAs for bladder cancer diagnosis and clinical outcome. J. Mol. Diagnos 15:695–705. doi:10.1016/j.jmoldx.2013.05.008.
   PubMed Web of Science ®Google Scholar
• Shukla, P., C. Vogl, B. Wallner, D. Rigler, M. Muller, and S. Macho-Maschler. 2015. High-throughput mRNA and miRNA profiling of epithelial-mesenchymal transition in MDCK cells. BMC Genom 16:944. doi:10.1186/s12864-015-2036-9.
   PubMed Web of Science ®Google Scholar
• Siegel, R. L., K. D. Miller, and A. Jemal. 2018. Cancer statistics, 2018. CA. Cancer J. Clin. 68:7–30. doi:10.3322/caac.21442.
   PubMed Web of Science ®Google Scholar
• Sundar, I. K., K. Rashid, J. Gerloff, J. Rangel-Moreno, D. Li, and I. Rahman. 2018. Genetic ablation of histone deacetylase 2 leads to lung cellular senescence and lymphoid follicle formation in COPD/emphysema. Faseb J. 32:4955–71. doi:10.1096/fj.201701518R.
   PubMed Web of Science ®Google Scholar
• Taylor, S. C., and A. Posch. 2014. The design of a quantitative western blot experiment. Biomed. Res. Int. 2014:361590. doi:10.1155/2014/361590.
   PubMed Web of Science ®Google Scholar
• Zhang, D., H. Lee, Z. Zhu, J. K. Minhas, and Y. Jin. 2017. Enrichment of selective miRNAs in exosomes and delivery of exosomal miRNAs in vitro and in vivo. Am. J. Physiol. Lung Cell Mol. Physiol. 312:L110–L121. doi:10.1152/ajplung.00423.2016.
   PubMed Web of Science ®Google Scholar
• Zhang, L. Q., Y. Wang, and L. Zhang. 2015. Effects of shRNA-mediated knockdown of SPOCK1 on ovarian cancer growth and metastasis. Cell. Mol. Biol. 61:102–09.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., and R. A. Weinberg. 2018. Epithelial-to-mesenchymal transition in cancer: Complexity and opportunities. Front Med. 12:361–73. doi:10.1007/s11684-018-0656-6.
   PubMed Web of Science ®Google Scholar
• Zhou, Y. M., J. Liu, and W. Sun. 2014. MiR-130a overcomes gefitinib resistance by targeting Met in non-small cell lung cancer cell lines. Asian Pac. J. Cancer Prevent 15:1391–96. doi:10.7314/Apjcp.2014.15.3.1391.
   PubMedGoogle Scholar